タグシクス・バイオ株式会社

formerly Tagcyx BiotechnologiesAcquired

TAGCyx Biotechnologies, Inc.|Aptamer Apheresis R&D of Nucleic Acid Medicine

Meguro, Japan · Founded 2007

Headquarters
Meguro, Tokyo
Founded
2007
Business Model
B2B
Website
tagcyx.com
Last Round
Venture RoundJul 2021
Rounds
1

About

TAGCyx Biotechnologies, Inc. (タグシクス・バイオ株式会社) is a Tokyo-based biotechnology company founded in 2007 that creates candidate compounds for high-performance nucleic acid drugs with high affinity and specificity for target molecules, using its proprietary nucleic acid basic technology. The company has partnered with FRONTEO, Inc. on a proof-of-concept (PoC) contract applying the Drug Discovery AI Factory platform to search for new target molecules and indications for its artificial nucleic acid aptamers.

Summary

タグシクス・バイオ株式会社 is a Biotech company based in Meguro, Japan, founded in 2007. Its most recent funding was a Venture Round round in Jul 2021. Investors include UTokyo Innovation Platform and SBI Investment.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

MergerJan 2025

Sign up to see all 2 rounds

Venture Round through Merger — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

タグシクス・バイオ株式会社 on Indexed.vc
<a href="https://indexed.vc/companies/tagcyx"><img src="https://indexed.vc/api/badge/company/tagcyx" alt="タグシクス・バイオ株式会社 on Indexed.vc" width="260" height="76" /></a>